| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 170.81B | 165.54B | 146.19B | 131.05B | 111.83B | 116.38B |
| Gross Profit | 17.20B | 16.55B | 15.80B | 13.70B | 12.67B | 14.38B |
| EBITDA | 3.40B | 3.37B | 3.44B | 2.29B | 2.35B | 3.99B |
| Net Income | 2.59B | 2.36B | 2.02B | 1.77B | 1.64B | 2.03B |
Balance Sheet | ||||||
| Total Assets | 76.63B | 79.97B | 75.34B | 69.41B | 60.93B | 60.47B |
| Cash, Cash Equivalents and Short-Term Investments | 6.95B | 7.99B | 10.35B | 8.35B | 8.08B | 14.59B |
| Total Debt | 11.68B | 13.48B | 15.88B | 14.63B | 12.55B | 12.21B |
| Total Liabilities | 47.18B | 49.88B | 47.88B | 43.48B | 36.41B | 37.22B |
| Stockholders Equity | 29.45B | 30.09B | 27.45B | 25.93B | 24.51B | 23.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.66B | 34.00M | -1.79B | -7.34B | 5.29B |
| Operating Cash Flow | 0.00 | 2.71B | 183.00M | -1.72B | -7.08B | 5.38B |
| Investing Cash Flow | 0.00 | -955.00M | 1.49B | 1.26B | 622.00M | -115.00M |
| Financing Cash Flow | 0.00 | -4.22B | 43.00M | 632.00M | -481.00M | -2.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥169.54B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
77 Outperform | ¥814.09B | 3.29 | 27.58% | 0.99% | 9.49% | 55.64% | |
75 Outperform | ¥122.25B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
74 Outperform | ¥31.22B | 10.50 | ― | 3.91% | 9.88% | 25.92% | |
66 Neutral | ¥137.72B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥1.64T | 117.21 | 3.37% | 1.85% | -2.18% | 26.45% |